Clinical Trials Logo

Fertility clinical trials

View clinical trials related to Fertility.

Filter by:

NCT ID: NCT02878434 Recruiting - Cancer Clinical Trials

Fertility Preservation in Young Women With Cancer

Start date: May 23, 2017
Phase:
Study type: Observational [Patient Registry]

The researchers aim to record the incidence, treatment and long term follow up of fertility preserving cancer treatment. Both the oncological and fertility outcome are recorded. Study population: All patients with a cancer for whom a fertility preserving cancer treatment is applied. The results of the study population are compared to young women undergoing standard cancer treatment.

NCT ID: NCT02462278 Recruiting - Fertility Clinical Trials

Measuring Core Body Temperature Using TempuRing

Start date: July 2015
Phase: N/A
Study type: Interventional

This study evaluates the safety and usability of a continuous temperature sensor for women. Data will compare the date of ovulation identified by the continuous temperature sensor to that of transvaginal ultrasound and serum progesterone levels. Subjects will also compare sensor results to once-daily oral temperatures and urine luteinizing hormone (LH) status.

NCT ID: NCT00902720 Recruiting - Fertility Clinical Trials

Ovarian Tissue Freezing For Fertility Preservation

Start date: May 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to offer an alternative method to women who wish to preserve the possibility of fertility, as well as to learn more about the ability of human eggs to survive and function after long term storage in frozen ovaries (ovarian tissue cryopreservation). The study will seek to preserve ovarian tissue and reproductive potential for patients whose medical or surgical treatment may harm ovaries or remove ovarian tissue.

NCT ID: NCT00327639 Recruiting - Pregnancy Clinical Trials

Factors Promoting Increased Rate and Success of Pregnancy in the Thalassemia Population in Toronto

Start date: July 2005
Phase: N/A
Study type: Observational

Treatment of patients with beta thalassemia in North America has altered dramatically during the past 40 years, with improvements in transfusion therapy and introduction of iron chelation therapy. Thalassemia patients now enjoy an increased life expectancy to the fifth and sixth decades of life, with fertility and childbearing becoming important issues. Data regarding this important topic remain limited, without clear data regarding iron control including serial assessment of hepatic iron concentration, the need for assistance in becoming pregnant, and use of iron chelating agents during pregnancy. As the life expectancy increases and overall health improves in thalassemia, clear data on fertility, pregnancy complications, and the effect of pregnancy on maternal health in thalassemia patients are necessary since these will have a direct impact on patient care, quality of life, and patient expectations.